Back

Cardiac transthyretin amyloidosis in patients with conduction system disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jiri Pudich

University Hospital Ostrava, Ostrava (Czechia)

4 More presentations in this session

Presentation thumbnail
Pyrophosphate scintigram as a potential imaging index of therapeutic efficacy for transthyretin cardiac amyloidosis
Mr S. Saito (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
Two-year cardiac follow-up of transthyretin amyloid deposition in surgical specimens from carpal tunnel syndrome and rotator cuff tear cases
Assistant Professor T. Umemoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Spatial transcriptomics of human cardiac biopsy samples reveals gene expression signature of cardiac amyloidosis
Mr S. Saito (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
Acoramidis-mediated improvement in NT-proBNP at month 30 compared with placebo in patients with ATTR-CM: results from the ATTRibute-CM study
Doctor N. Sarswat (Chicago, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac amyloidosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Transthyretin cardiac amyloidosis
thumbnail
Congress Session
Cardiac amyloidosis: my heart is filled with so much…
thumbnail
Congress Session
The evolving landscape of transthyretin amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources